Welcome to Assay Development & High-throughput Screening

Venue: San Francisco

Location: San Francisco, United States

Event Date/Time: Apr 05, 2006
Report as Spam


Michele Dowless
Asst. Sr Biologist, Cell Growth and Translational Genetics, Eli Lilly & Co.

YingPing Zhang
Senior Automation Engineer, Pfizer Inc.

Changhua Ji, M.D., Ph.D.
Research Scientist II, Viral Disease Therapy, Roche Palo Alto

Arunan Kaliyaperumal
Senior Scientist, Department of Clinical Immunology, Amgen Inc.

Robert J. Pascoe, Ph.D.
Principal Scientist, RAS-Analytical, Merck & Co. Inc.

Dominique Perrin, Ph.D.
Group Leader, Biochemical Pharmacology, Serono Pharmaceutical Research Institute

Anton Beletskii
GE Global Research Center

John Morin, Ph.D.
Director, High-Throughput Screening, Wyeth Research

Jun Wang, Ph.D.
Principal Scientist, Human Genetics Department, Roche Molecular Systems

John Wang
Associate Director, Drug Lead Discovery, Chiron Corporation

Abraham Oommen, Ph.D.
Chief Executive Officer, GeneSeek AG

Christian Korherr, Ph.D.
Group Leader, Molecular and Cell Biology, Xantos Biomedicine AG

Robert Bostwick, Ph.D.
Assoc. Director & Head, Assay Development and HTS, Lead Generation, AstraZeneca Pharmaceuticals

Vincent Dupriez, Ph D.
Head, Molecular Biology & Assay Design, EUROSCREEN S.A.

Paul Lang, Ph.D.
Head, Cellular Pharmacology, Serono Pharmaceutical Research Institute

Daniel Johnson, Ph.D.
Senior Scientist, Assay Development, Amphora Corporation

Constance Höfer
Consultant, Cyprotex

Gerald Kleymann
University of Tübingen

Gloria Meng, Ph.D.
Assay and Automation Technology, Genentech Inc.

Bin Zhang, Ph.D.
Group leader and Principle Investigator, Dept of Chemical Biology, ArQule Inc.

Bin Li
Associate Director, Lead Discovery, Anadys Pharmaceuticals

Mathias Ehrich
Sequenom, Inc.

Peter J. Tummino, Ph.D.
MMPD Enzymology & Mechanistic Pharmacology, GlaxoSmithKline Pharmaceuticals

Ron L. Johnson, Ph.D.
Team Leader, Molecular Genetic Assay Technologies, Biomolecular Screening and Profiling, NIH Chemical Genomics Center

Serene Josiah, Ph.D.
Consultant, Active Drug Design, LLC